The chromosomal locations of the genes purG and purI on the Escherichia coli linkage map are the opposites of those of Salmonella typhimurium. By methods which permit the identification of lesions in any of the five early enzymes of the purine de novo pathway, the gene-enzyme relationships of the purG and purl loci have been reevaluated in these two organisms. The results demonstrate that the relative locations of the genes encoding the two enzymes (phosphoribosylformylglycinamidine synthetase and phosphoribosylaminoimidazole synthetase) are similar in the two organisms. The gene products have been correctly determined in S. typhimurium. The gene products currently listed for the loci in E. coli are incorrect. The E. coli purG locus is equivalent to the S. typhimurium purl locus, and the E. coli purI locus is equivalent to the S. typhimurium purG locus.
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In Salmonella typhimurium and in Escherichia coli, 14 enzymatic reactions are involved in the de novo biosynthesis of AMP and GMP. Twelve genes encoding the enzymes involved have been localized on the S. typhimurium chromosome. The genes occur mostly as unlinked single units or as small functional operons guaA and B and purJ, H, and D (1, 2, 8). One of the genes, purB, encodes a bifunctional enzyme known to catalyze two reactions of the pathway (2). In E. coli, analogous positions have been found for nine of the genes, and the positions for purI and purG are reversed (7, 11) . purJ mutants have not been identified (1, 9). Mutants with a defective phosphoribosylglycinamide (GAR) formyltransferase (see Table 1 ) have not been found for either S. typhimurium or E. coli.
Mutations affecting the biosynthesis of inosine monophosphate can be classified into two groups. The first group includes defects in any of the five early enzymes, and the second group includes defects in any of the five late enzymes. Mutants which are defective in one of the five late enzymes excrete diazotizable amines when starved for purines (10, 12) , whereas mutants blocked in one of the early steps ( phoribosylformylglycinamide [FGAR] and FGAM) of the purine de novo pathway during purine starvation.
We observed that early purine auxotrophs, (purF, purD, purG, and purI) of S. typhimurium accumulated phosphoribosylpyrophosphate when starved for purines. The most dramatic accumulation is seen in purF mutants (4) . Furthermore, purG mutants accumulate FGAR, and purl mutants accumulate both FGAR and FGAM, when starved for purines (Fig. 1A ). Phosphoribosylamine accumulation is not observed with purD mutants, presumably owing to the lability of the compound (12) . Mutants defective in the synthesis of the third enzyme of the pathway could be expected to accumulate GAR when starved for purines. When a similar approach was used with E. coli purine auxotrophs, there was a different pattern in the accumulation of FGAR and FGAM by particular mutants. Specifically, a purported purG mutant accumulated FGAR and FGAM, but a purported purI mutant accumulated only FGAR when starved for purines (Fig. 1B) . To confirm the nature of the indicated enzyme deficiency, enzymatic analyses were carried out on cell-free extracts.
For the determination of FGAM formation in cell-free extracts, we developed a new assay which also allows the determination of FGAR formation. In principle, it is an improvement and simplification of the assay developed by Westby and Gots (12) for GAR and FGAR synthesis, an assay which involves the sequential action of the first enzymes of the de novo pathway.
The results for the mutant strains harboring defects in the early enzymes of the purine de Table 2 ). Cells exponentially in glucose minimnal medium 0.3 mM phosphate (4) . At an optical densit of 1, the cells were harvested and suspenc medium with no hypoxanthine added but 32Pi (33 uCi/Rmol). After 2 h of incubatio were extracted with formic acid (4). The novo pathway are given in Table 2 . The S. typhimurium purG strain had no FGAM synthetase activity, as expected, but the E. coli purG strain showed activity. The reverse pattern was observed with the purI strains; the purI mutant of S. typhimurium possessed FGAM synthetase activity, but the E. coli purI mutant showed no activity. On the current E. coli linkage map, the purine de novo gene which is located close to upp is purG (11) , and yet FGAM synthetase activity was observed in the upp-purG deletion mutant of E. coli. From the results, it is evident *. * that the enzymatic defects of the purG and pairl genes in E. coli have been misinterpreted. In agreement with our data, it has been observed that ColE1-purl plasmids which complemented * * S. typhimurium purI mutants also complemented purG, but not purl, mutants of E. coli (J. S. Gots, personal communication a In agreement with the results presented, E. coli purG should be designated purM, whereas purI should be named purL.
b Cultures for enzymatic analyses were grown in glucose minimal medium at 37°C (6) . Amino acids were added to a final concentration of 40 ,ug/ml, hypoxanthine to 15 ,ug/ml, and thiamine to 1 ,ug/ml. Cell growth was monitored in an Eppendorf photometer at 436 nm. An optical density of 1 (1 cm light path) corresponds to about 3 x 108 cells per ml. Cells were grown exponentially for several generations. At an optical density of 0.6, the cells were transferred to fresh medium without hypoxanthine. After 2 h of purine starvation, which causes a derepression of the synthesis of the purine de novo enzymes, the cells were harvested and suspended in 30 mM potassiitm phosphate, pH 7.0, containing 1 mM EDTA and 1 mM dithiothreitol, disrupted by sonication, and centrifuged for 5 min at 6,000 x g. The supernatant was desalted by passage through a Sephadex G-25 column equilibrated with the extraction buffer. Protein was determined as described by Lowry et al. c FGAR and FGAM synthesis are not observed with purF and purD mutants because the assay procedure is a coupled assay which depends on the presence of both the purF and the purD encoded enzymes in the extract.
d Obtained through the E. coli Genetic Stock Center.
cation of defects in one of the five early enzymes of the purine biosynthetic pathway. Purine auxotrophs belonging to this group grow on hypoxanthine as the sole purine source and do not excrete diazotizable compounds when starved for purines. Mutants defective in either of the first two enzymes do not accumulate any intermediary compound of the pathway (Fig. 1) , and no FGAR formation can be demonstrated in cell-free extracts. However, FGAR formation occurs when cell-free extracts of purF and purD mutants are combined, and thus by the use of cell extracts from known purF and purD mutant strains, the nature of the enzyme defect can be determined. Mutants defective in one of the three other enzymes can be identified by determining the intermediary compounds which accumulate during purine starvation ( Fig. 1) and by determining GAR, FGAR, and FGAM formation in cell-free extracts.
